Cimi-Fem

product on market Tablet or Pill Source Naturals Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Cimi-Fem
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
120
Servings
Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 80.0mg (136 products)

Other Ingredients

Mannitol Sorbitol natural Chocolate flavor Hydroxypropyl Methylcellulose natural Peppermint flavor Colloidal Silicon Dioxide Stearic Acid Magnesium Stearate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: 1 to 2 tablets twice daily. Place tablet under the tongue and allow to dissolve slowly, altering the position of the tablet to avoid prolonged contact with the same area. For best results, use this product for at least 4 weeks.

Warnings & Precautions

Warning: Do not use if you are pregnant, may become pregnant, or breastfeeding.

Do not use if either tamper-evident seal is broken or missing.

Keep out of the reach of children.

Formulation Notes

Black cohosh sublingual

May help reduce hot flashes

During pre-menopause, excess luteinizing hormone is released from the pituitary gland in a futile attempt to raise estrogen levels. Source Naturals Cimi-Fem black cohosh sublingual tablets contain phytoestrogens and other compounds which may help reduce the frequency of hot flashes.

The sublingual form is absorbed directly into the bloodstream, via the blood vessels under the tongue and into cheeks, bypassing digestion and allowing for quick entry into the system.

Metadata

Product Details

UPC / SKU0 21078 01069 2
DSLD Entry Date2023-06-22
Product TypeBotanical
FormTablet or Pill
DSLD ID295648
Data Updated2026-04-11
Research

Research Evidence

31
Research Sources
49
Avg Quality
23
Systematic Review
5
Meta Analysis
1
Rct
1
Openfda Safety
B [Efficacy of black cohosh extracts for improving low estrogen status induced by postoperative GnRHa treatment in patients with endometriosis: a systematic review]
Systematic Review Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 2020 PubMed
B Black cohosh (Cimicifuga spp.) for menopausal symptoms
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
B Vasomotor symptoms resulting from natural menopause: a systematic review and network meta-analysis of treatment effects from the National Institute for Health and Care Excellence guideline on menopause
Systematic Review BJOG : an international journal of obstetrics and gynaecology 2017 PubMed DOI
C Suspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extract
Meta Analysis Menopause (New York, N.Y.) 2011 PubMed DOI
C Review & meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms - an update on the evidence
Meta Analysis Climacteric : the journal of the International Menopause Society 2021 PubMed DOI
C Menopausal symptoms
Systematic Review BMJ clinical evidence 2007 PubMed
C Menopausal symptoms
Systematic Review BMJ clinical evidence 2011 PubMed
C Menopausal symptoms
Systematic Review BMJ clinical evidence 2010 PubMed
C Black cohosh extracts in women with menopausal symptoms: an updated pairwise meta-analysis
Meta Analysis Menopause (New York, N.Y.) 2023 PubMed DOI
C Efficacy of black cohosh-containing preparations on menopausal symptoms: a meta-analysis
Meta Analysis Alternative therapies in health and medicine 2010 PubMed
View all evidence for Black Cohosh →
Compare

Similar Products

View all Black Cohosh products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.